← Back
$ACAD All transactions

ACADIA PHARMACEUTICALS INC

A

$ Value

$0

Shares

13,793

Price

$0

Filed

Jun 2

Insider

Name

SOLAND DANIEL B

Title

CIK

0001318485

Roles

Director

Transaction Details

Transaction Date

2025-05-29

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,793

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. | The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held. | The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders. | The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders.

Filing Info

Accession No.

0001415889-25-015275

Form Type

4

Issuer CIK

0001070494

SOLAND DANIEL B's History

Date Ticker Type Value
2025-05-29 ACAD M
2025-05-29 ACAD M $0
2025-05-29 ACAD A $0
2025-05-29 ACAD A $0

Other Insiders at ACAD (90d)

Insider Bought Sold Last
Rhodes Jennifer J
EVP, CHIEF LEGAL OFFICER, SEC
$83K 2026-03-25
Kihara James
PRINCIPAL ACCOUNTING OFFICER
$65K 2026-04-07
Owen Adams Catherine
Chief Executive Officer
$250K 2026-03-25
Thompson Elizabeth H.Z.
EVP, Head of Research & Dev
$74K 2026-03-25
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
$219K 2026-04-07